|
Market Closed -
Euronext Paris
11:55:00 2026-08-13 am EDT
|
5-day change | 1st Jan Change | ||
| 0.2890 EUR | +1.94% |
|
-1.37% | -14.24% |
| Market Cap | 149M 172M 140M 127M 239M 16.37B 243M 1.64B 641M 8.21B 644M 630M 27.36B | P/E 2026 * |
-38.5x | P/E 2027 * | -6.42x |
|---|---|---|---|---|---|
| Enterprise Value | 16.75M 19.32M 15.73M 14.32M 26.91M 1.84B 27.36M 185M 72.16M 924M 72.52M 70.92M 3.08B | EV / Sales 2026 * |
0.77x | EV / Sales 2027 * | 23.3x |
| Free-Float |
70.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.94% | ||
| 1 week | -1.37% | ||
| Current month | +1.76% | ||
| 1 month | +11.15% | ||
| 3 months | -35.13% | ||
| 6 months | -14.75% | ||
| Current year | -14.24% |
| 1 week | 0.28 | 0.3 | |
| 1 month | 0.25 | 0.31 | |
| Current year | 0.22 | 0.81 | |
| 1 year | 0.22 | 0.81 | |
| 3 years | 0.15 | 1.04 | |
| 5 years | 0.15 | 2.29 | |
| 10 years | 0.15 | 7.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 59 | 2026-05-31 |
Laurene Danon
DFI | Director of Finance/CFO | - | 2024-06-25 |
Bernd Schmidt
CTO | Chief Tech/Sci/R&D Officer | - | 2023-12-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2015-03-08 | |
Julien Miara
BRD | Director/Board Member | 43 | - |
Khalil Barrage
CHM | Chairman | 61 | 2023-03-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 2/6/26 | Redmile Biopharma Investments III LP
| Buy | Company | 18,928,571 | 6.2956% | |
| 1/31/26 | Sofinnova Partners SAS
| Buy | Company | 10,714,285 | 3.5636% | |
| 4/18/24 | Redmile Biopharma Investments III LP
| Buy | Company | 2,781,914 | 1.0091% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.94% | -1.37% | -7.96% | -21.89% | 168M | ||
| +1.17% | +2.03% | +4.91% | +15.74% | 48.72B | ||
| -1.59% | +2.38% | +472.89% | +573.56% | 43.99B | ||
| -0.85% | +8.70% | +23.57% | +80.09% | 40.82B | ||
| -0.08% | +2.32% | +29.91% | +9.86% | 39.79B | ||
| 0.00% | +6.15% | +23.03% | +48.00% | 32.7B | ||
| -2.52% | -0.99% | +26.71% | +118.05% | 16.66B | ||
| -3.61% | +0.83% | - | - | 16.84B | ||
| +0.72% | +0.60% | +4.97% | +21.70% | 13.95B | ||
| -1.09% | +7.88% | +84.14% | +31.15% | 13.58B | ||
| Average | -0.59% | +3.02% | +73.57% | +97.36% | 26.72B | |
| Weighted average by Cap. | -0.59% | +3.65% | +102.27% | +135.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.86M 25.21M 20.52M 18.69M 35.11M 2.41B 35.69M 241M 94.14M 1.21B 94.61M 92.52M 4.02B | 6.4M 7.37M 6M 5.47M 10.27M 704M 10.44M 70.49M 27.54M 353M 27.68M 27.07M 1.18B |
| Net income | -237K -273K -222K -202K -380K -26.04M -386K -2.61M -1.02M -13.06M -1.02M -1M -43.52M | -36.12M -41.65M -33.91M -30.88M -58.02M -3.97B -58.98M -398M -156M -1.99B -156M -153M -6.64B |
| Net Debt | -132M -152M -124M -113M -212M -14.53B -216M -1.45B -568M -7.28B -571M -559M -24.27B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | €0.2890 | +1.94% | 1,142,885 |
| 26-08-12 | €0.2835 | -2.24% | 716,555 |
| 26-08-11 | €0.2900 | -0.85% | 572,034 |
| 26-08-10 | €0.2925 | +1.21% | 562,204 |
| 26-08-07 | €0.2890 | +1.58% | 720,450 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALSEN Stock
Select your edition
All financial news and data tailored to specific country editions
















